3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
11
HER2-positive Breast Cancer
5
Rare Tumour
1
Metastatic Breast Cancer in the Brain
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Digestive System Tumor
1
Interventions
spartalizumab
1
sintilimab
1
pyrotinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Advanced Digestive System Tumor
×
pyrotinib
×
Clear all
NCT07053150
2025-07-08
CCGLC-018
Tongji Hospital
Phase 2
Not yet recruiting
80 enrolled